1fng: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /><applet load="1fng" size="450" color="white" frame="true" align="right" spinBox="true" caption="1fng, resolution 1.90Å" /> '''HISTOCOMPATIBILITY A...
 
No edit summary
Line 1: Line 1:
[[Image:1fng.gif|left|200px]]<br /><applet load="1fng" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1fng.gif|left|200px]]<br /><applet load="1fng" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1fng, resolution 1.90&Aring;" />
caption="1fng, resolution 1.90&Aring;" />
'''HISTOCOMPATIBILITY ANTIGEN'''<br />
'''HISTOCOMPATIBILITY ANTIGEN'''<br />


==Overview==
==Overview==
To better understand TCR discrimination of multiple ligands, we have, analyzed the crystal structures of two Hb peptide/I-E(k) complexes that, differ by only a single amino acid substitution at the P6 anchor position, within the peptide (E73D). Detailed comparison of multiple independently, determined structures at 1.9 A resolution reveals that removal of a single, buried methylene group can alter a critical portion of the TCR recognition, surface. Significant variance was observed in the peptide P5-P8 main chain, as well as a rotamer difference at LeuP8, approximately 10 A distal from, the substitution. No significant variations were observed in the, conformation of the two MHC class II molecules. The ligand alteration, results in two peptide/MHC complexes that generate bulk T cell responses, that are distinct and essentially nonoverlapping. For the Hb-specific T, cell 3.L2, substitution reduces the potency of the ligand 1000-fold., Soluble 3.L2 TCR binds the two peptide/MHC complexes with similar, affinity, although with faster kinetics. These results highlight the role, of subtle variations in MHC Ag presentation on T cell activation and, signaling.
To better understand TCR discrimination of multiple ligands, we have analyzed the crystal structures of two Hb peptide/I-E(k) complexes that differ by only a single amino acid substitution at the P6 anchor position within the peptide (E73D). Detailed comparison of multiple independently determined structures at 1.9 A resolution reveals that removal of a single buried methylene group can alter a critical portion of the TCR recognition surface. Significant variance was observed in the peptide P5-P8 main chain as well as a rotamer difference at LeuP8, approximately 10 A distal from the substitution. No significant variations were observed in the conformation of the two MHC class II molecules. The ligand alteration results in two peptide/MHC complexes that generate bulk T cell responses that are distinct and essentially nonoverlapping. For the Hb-specific T cell 3.L2, substitution reduces the potency of the ligand 1000-fold. Soluble 3.L2 TCR binds the two peptide/MHC complexes with similar affinity, although with faster kinetics. These results highlight the role of subtle variations in MHC Ag presentation on T cell activation and signaling.


==About this Structure==
==About this Structure==
1FNG is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with NAG as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1FNG OCA].  
1FNG is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=NAG:'>NAG</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1FNG OCA].  


==Reference==
==Reference==
Line 13: Line 13:
[[Category: Mus musculus]]
[[Category: Mus musculus]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Fremont, D.H.]]
[[Category: Fremont, D H.]]
[[Category: Miley, M.J.]]
[[Category: Miley, M J.]]
[[Category: Nelson, C.A.]]
[[Category: Nelson, C A.]]
[[Category: NAG]]
[[Category: NAG]]
[[Category: histocompatibility antigen]]
[[Category: histocompatibility antigen]]
Line 22: Line 22:
[[Category: peptide]]
[[Category: peptide]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 15:03:55 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:40:31 2008''

Revision as of 13:40, 21 February 2008

File:1fng.gif


1fng, resolution 1.90Å

Drag the structure with the mouse to rotate

HISTOCOMPATIBILITY ANTIGEN

OverviewOverview

To better understand TCR discrimination of multiple ligands, we have analyzed the crystal structures of two Hb peptide/I-E(k) complexes that differ by only a single amino acid substitution at the P6 anchor position within the peptide (E73D). Detailed comparison of multiple independently determined structures at 1.9 A resolution reveals that removal of a single buried methylene group can alter a critical portion of the TCR recognition surface. Significant variance was observed in the peptide P5-P8 main chain as well as a rotamer difference at LeuP8, approximately 10 A distal from the substitution. No significant variations were observed in the conformation of the two MHC class II molecules. The ligand alteration results in two peptide/MHC complexes that generate bulk T cell responses that are distinct and essentially nonoverlapping. For the Hb-specific T cell 3.L2, substitution reduces the potency of the ligand 1000-fold. Soluble 3.L2 TCR binds the two peptide/MHC complexes with similar affinity, although with faster kinetics. These results highlight the role of subtle variations in MHC Ag presentation on T cell activation and signaling.

About this StructureAbout this Structure

1FNG is a Protein complex structure of sequences from Mus musculus with as ligand. Full crystallographic information is available from OCA.

ReferenceReference

Structural and functional consequences of altering a peptide MHC anchor residue., Kersh GJ, Miley MJ, Nelson CA, Grakoui A, Horvath S, Donermeyer DL, Kappler J, Allen PM, Fremont DH, J Immunol. 2001 Mar 1;166(5):3345-54. PMID:11207290

Page seeded by OCA on Thu Feb 21 12:40:31 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA